GBA Presents: RADIO SAVANT-!

vanzandt said:
Prediction: Oil inventories will show a surprise climb in tomorrow's report.
Has the bear has entered the oil patch? Could that happen? He's mauled tech and retail. What's left? Finance, healthcare, and energy. :wtf:
More...

So I looked. Energy stocks are only about 3% of the S&P.
Are the whales crashing tech as they sell energy to rotate back into tech for cheap?

Ancient astronaut theorists say yes!
Tech rally on the way!
 
Volume on the Q's 29% below average on a 20 day moving window.
Run em way down... buy the calls with strikes in the high $290's for pennies, and then run em right back up and make millions and millions.
It's great to be a whale with algo's written by scientists and billions of aum.
They are our kings.
They are the Lizard-Men Stoney!
 
Palantir Technologies CEO sees 20%-30% risk of nuclear war

What the hell.
  • Palantir Technologies (NYSE:PLTR) CEO Alex Karp said he sees a 20%-30% risk of nuclear war over time.
  • "If you have a long duration I think the risk is modellable, probably in like the 20% to 30% range," Karp said in an interview on CNBC from Davos, Switzerland.
  • Karp discussed the possibility of a nuclear war on the company's Q1 results call earlier this month and said that probability of such an event seems to be underreported.
  • "The risk of a nuclear event is so much higher than it's being presented in the public world, that it’s almost surreal to watch the coverage," Karp said on the call.
  • Recall in March a research firm wrote that it saw a 10% chance of a nuclear apocalypse in the next year.
 
stonedinvestor said:
Canadian Solar reports Q1 EPS 14c, consensus (13c) 06:05 CSIQ Reports Q1

Albemarle price target raised to $320 from $290 at Deutsche Bank 06:49 ALB Deutsche Bank analyst…

Albemarle price target raised to $320 from $285 at Wells Fargo » 06:46 ALB Wells Fargo anal

Albemarle price target raised to $314 from $300 at RBC Capital 06:23 ALB RBC Capital analyst Arun Viswanathan raised the firm's price target on Albemarle to $314 from $300 and keeps an Outperform rating on the shares after the company raised its FY22 guidance due to better than expected progress in shifting Lithium customers towards variable priced contracts. Viswanathan adds that he has lowered his forward EBITDA multiple estimate to 20-times from 22-times due to "peak pricing", though his FY23 outlook of $2B is below consensus $2.1B to "build in a cushion" as pricing moderates.

AST SpaceMobile price target lowered to $31 from $32 at Deutsche Bank » 06:48 ASTS Deutsche Bank analyst…

Citi Trends reports Q1 adjusted EPS 42c, consensus 34c » 06:47 CTRN Reports Q1 revenue $208M,…

STOCK OF THE DAY- HILLEVAX

HilleVax initiated with a Buy at Guggenheim 06:22 HLVX Guggenheim analyst Seamus Fernandez initiated coverage of HilleVax with a Buy rating and $40 price target.

->GUMMY- HLVX $9.50
More...



take profit bros & gals--- he's done it again.! :wtf::thumbsup::thumbsup::thumbsup::thumbsup::thumbsup:
 
Wow HOLX is a monster! You would think with Covid testing slowdown... But no.

Hologic, Inc. (HOLX) Just saw the ticker.
NasdaqGS - NasdaqGS
78.24-0.57 (-0.72%)
As of 12:39PM EDT. Market open.
 
You must log in or register to reply here.
Back
Top